Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Anushka Bakshi

Gradually, then suddenly

Company extinction is the result of cognitive shortcomings

- PMLiVE

US government shutdown leaves FDA running on empty

Funding row means shutdown could break 21 day record

PM Society Awards

Page & Page has been shortlisted for an award!

Page & Page are excited to be shortlisted for a PM Society Award

Page & Page Health

Bear and Two Foxes

Givers and Takers

Have we lost the ability to identify the difference between net givers and net takers of energy?

Page & Page Health

- PMLiVE

Ashfield joins forces with Argon Global Healthcare Network

Agency aims to expand with new partnership

- PMLiVE

NICE rejects Novartis migraine treatment Aimovig

A draft 'no' to first-in-class treatment, despite discount

- PMLiVE

Nektar confirms BMS deal for NKTR-214 is on track

Shares in Nektar rose 10% in the wake of the presentation at JPM healthcare conference

- PMLiVE

EMA sees approval numbers rise in 2018

Agency faces Brexit test in 2019

- PMLiVE

Moderna CEO makes case for firm’s lofty valuation

mRNA specialist has to convince investors after stocks slide

Joint working that works

Dovetail

Q&A with Dr Timothy Vollmer, leading MS Neurologist

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face...

Blue Latitude Health

- PMLiVE

Novartis gets breakthrough tag from FDA for sickle cell drug

Latest pipeline therapy for painful blood disorder

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links